USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
06 Sep 2023 | 03:00 PM GMT

Pharma 3.0: A framework for doing digital health better

Anchored by:

Frank Chavez
Global Head, Strategy & Corporate Development
OTSUKA PRECISION HEALTH

Participants:

Frank Chavez Global Head, Strategy & Corporate DevelopmentOtsuka Precision Health
Frank Chavez
Global Head, Strategy & Corporate DevelopmentOtsuka Precision Health
Chandana Fitzgerald President, CommunityHLTH
Chandana Fitzgerald
President, CommunityHLTH
Doug Burgener Marketing DirectorBiofourmis
Doug Burgener
Marketing DirectorBiofourmis
Francisco Rausa Director, Digital Health & InnovationAbbvie
Francisco Rausa
Director, Digital Health & InnovationAbbvie
Louise O'Mahony Head of Customer SuccessEXi
Louise O'Mahony
Head of Customer SuccessEXi
Mitesh Daftardar Digital Innovation Hub LeadMerz Therapeutics
Mitesh Daftardar
Digital Innovation Hub LeadMerz Therapeutics
Renaldo Bernard Product ManagerMerck Group
Renaldo Bernard
Product ManagerMerck Group
Rick Bartels President/Founder DTxCC
Rick Bartels
President/Founder DTxCC
Ron Hashomnay Board MemeberRxWare
Ron Hashomnay
Board MemeberRxWare
Saad Shah Medical Director, Digital MedicineAmgen
Saad Shah
Medical Director, Digital MedicineAmgen
Susanne Gruber Strategic Healthcare AdvisorIgnited Vision
Susanne Gruber
Strategic Healthcare AdvisorIgnited Vision
Ventsislav Dobrev Global Clinical Lead Digital BiomarkersRoche
Ventsislav Dobrev
Global Clinical Lead Digital BiomarkersRoche

About this Meeting

Digital health’s interaction with pharma is evolving; it has to evolve. Digital innovation around and beyond the molecule has yet to demonstrate real value, ROI and scale. While digital health found refuge with pharma initially, market observers are now questioning whether pharma should lead this digital charge or simply be a main consumer.

Digital will be a part of pharma’s future, as consumers demand the digital convenience they now take for granted in other industries. Pharma is learning from the past and focusing their efforts into high-potential initiatives.

Our HealthXL report maps out the next phase for digital health in pharma. Leading experts from across our community have shared their thoughts on driving innovation in and for the pharmaceutical industry to understand what has happened to digital health in pharma and how it’s evolving.

Join us in this roundtable to discuss the highlights from the report and how pharma can do digital health better in the next few years.